Skip to main content Help with accessibility Skip to main navigation

FOSTAMATINIB tablets (Tavlesse®▼) for the treatment of refractory chronic immune thrombocytopenia

CCG Approval Status:

Date Added: 27 - Jan - 2022
Black

The Pan Mersey Area Prescribing Committee does not currently recommend
the prescribing of FOSTAMATINIB tablets (Tavlesse®▼) for the treatment of
chronic immune thrombocytopenia (ITP).